⚠ You're viewing a report from January 2025. Subscribe to get the latest →

FDA Enforcement — January 2025 Report

Automated analysis of 22 items from public government data sources. Updated daily.

Summary

22
Total items
20
High impact
2
Medium impact
0
Low impact

High-impact items this period

Strukmyer LLC dba Strukmyer Medical
Adulterated finished pharmaceuticals CGMP violations
Why: Manufacturing process non-compliance in pharmaceutical products  ·  Jan 30  ·  Impact: HIGH
AmWiner & Raphe Holdings, LLC dba rapheGenerics Corp
Finished pharmaceutical product adulteration CGMP violation
Why: Current Good Manufacturing Practice non-compliance in finished drug production  ·  Jan 29  ·  Impact: HIGH
Shantou Kangjie Daily Chemical Industry Co., Ltd
Adulterated finished pharmaceuticals CGMP violations
Why: Manufacturing deficiencies in finished pharmaceutical production  ·  Jan 28  ·  Impact: HIGH
Garcia Fresh Vegetables LLC
Foreign supplier verification program FSVP non-compliance
Why: Inadequate supplier verification and food safety controls for imports  ·  Jan 27  ·  Impact: HIGH
Imperial Palace Commodity -Dongguan- Co., Ltd.
Adulterated finished pharmaceuticals CGMP violations
Why: Manufacturing process non-compliance in finished drug products  ·  Jan 27  ·  Impact: HIGH
Center for Instrumental Analysis of China Pharmaceutical University
Adulterated active pharmaceutical ingredient CGMP violations
Why: Manufacturing deficiencies in API production quality standards  ·  Jan 23  ·  Impact: HIGH
Kardesler Ucan Yaglar Sanayi Anonim Sirketi
Adulterated finished pharmaceutical CGMP violations
Why: Manufacturing process deviations compromising pharmaceutical integrity  ·  Jan 21  ·  Impact: HIGH
Robbins Instruments, LLC
Medical device misbranded, unapproved, QSR violations
Why: Quality system regulation and device approval pathway non-compliance  ·  Jan 21  ·  Impact: HIGH
Chara Biologics, Inc.
CGMP deviations in biologics license application manufacturing
Why: Manufacturing process non-compliance for licensed biologic products  ·  Jan 17  ·  Impact: HIGH
BioStem Life Sciences
HCT/P regulatory deviations for cellular tissue products
Why: Non-compliance with human cell tissue product CFR requirements  ·  Jan 17  ·  Impact: HIGH

Selected medium-impact items

Talla Imports, LLC
Foreign supplier verification program non-compliance
Why: Inadequate verification procedures for imported food/drug products  ·  Jan 13  ·  Impact: MEDIUM
Elite Brothers, LLC
Tobacco product adulteration and misbranding violations
Why: Non-compliance with Tobacco Control Act requirements  ·  Jan 07  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →